infectious diseases

News

Race for hepatitis B drug intensifies as Antios raises $96m ...

Antios has raised $96 million in Series B financing to support the ongoing phase 2 development of its hepatitis B drug candidate, ATI-2173.

News

South African variant may evade Pfizer/BioNTech vaccine, stu...

The coronavirus variant discovered in South Africa may evade Pfizer/BioNTech’s vaccine, according to a real-world data study conducted in Israel.

News

Regeneron's antibody cocktail hits target in COVID preventio...

Regeneron is to ask the FDA for clearance to use its antibody cocktail as a preventive treatment for COVID-19.

News

Regeneron's antibody cocktail cuts COVID hospitalisation in ...

Regeneron has posted findings from a large trial of its COVID-19 antibody cocktail showing the therapy reduced risk of hospitalisation or death by 70%.

News

Pfizer begins clinical trials of COVID-19 antiviral pill

Pfizer has begun clinical development of an antiviral pill against COVID-19, which could be prescribed to patients at the first sign of infection.

Views & Analysis

Could a smartphone cough app stop future pandemics?

A host of companies are looking at cough apps to detect the presence of COVID-19.

Race for hepatitis B drug intensifies as Antios raises $96m ...

South African variant may evade Pfizer/BioNTech vaccine, stu...

Regeneron's antibody cocktail hits target in COVID preventio...

Regeneron's antibody cocktail cuts COVID hospitalisation in ...

Pfizer begins clinical trials of COVID-19 antiviral pill

Could a smartphone cough app stop future pandemics?

Threat of Trump's pharma tariffs looms again

Using AI-driven synthetic personas to take your insights fur...

infectious diseases

Editor's Picks